The efficacy of inhibiting tumour necrosis factor and interleukin 1 in patients with rheumatoid arthritis: a meta-analysis and adjusted indirect comparisons
New treatments that inhibit the cytokines tumour necrosis factor alpha (TNFalpha) and interleukin 1 (IL-1) in the treatment of rheumatoid arthritis have proven clinical effect against placebo and methotrexate (MTX) in several clinical trials in early and late-stage disease and different severity gro...
Salvato in:
Autori principali: | , , |
---|---|
Natura: | Revisão |
Lingua: | inglese |
Pubblicazione: |
2007
|
Accesso online: | https://doi.org/10.1093/rheumatology/kem072 https://academic.oup.com/rheumatology/article-pdf/46/7/1140/9449311/kem072.pdf |
Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|